One in Four Teen Girls and Young Women at Risk for PMOS: New Study Reveals Alarming Prevalence of Hormonal Disorder
CHICAGO — June 13, 2026 — More than one in four adolescent girls and young women carry at least one significant risk factor for polyendocrine...
Upstream Breakthrough: Novel Antibody Asedebart Normalizes Cortisol in Mid-Stage Cushing’s Disease Trial
CHICAGO — Danish pharmaceutical company H. Lundbeck A/S announced encouraging results from a mid-stage clinical trial of its investigational drug...
FDA Approves First Disease-Modifying Therapy for Stage 3 Type 1 Diabetes in Children: A Historic Breakthrough for Pediatric Diabetes Care
Published: June 15, 2026 SILVER SPRING, Md. — In a milestone decision that alters the landscape of pediatric endocrinology, the U.S. Food and Drug...
Geographic Expansion of Bundibugyo Ebola Strain in Congo Demands Urgent Public Health Mobilization
Published: June 15, 2026 KINSHASA, DEMOCRATIC REPUBLIC OF CONGO — The Democratic Republic of Congo (DRC) reported a dramatic single-day increase in...
Beyond Blood Sugar: Why Diabetes Multiplies the Risk of ‘Frozen Shoulder’
CHICAGO — For decades, clinical guidance on diabetes management has focused heavily on protecting the heart, kidneys, eyes, and feet. However, a...
